• Affordable Educational Credits
  • Watch At Your Convenience
  • Worldwide Speakers
  • Captivating Topics
  • Peer Interactions

Hyperbilirubinemia Online Course(s) & Continuing Education

Access the latest clinical skills and research for Hyperbilirubinemia for NEONATOLOGY professional training. These Hyperbilirubinemia online courses provide practice-changing skills and valuable perspectives from leading global experts. This Hyperbilirubinemia education has been accredited for a variety of CEUs / CERPs and can be accessed on-demand, at your own pace.

Hours / Credits: 1.25 (details)
Learn More
Canada Michael Narvey, MD, FAAP, FRCPC

Dr. Narvey began his training in Pediatrics at the University of Manitoba in Winnipeg where he completed a year of further training in Neonatology. This was followed by two years of Neonatal fellowship at the University of Alberta in Edmonton. Afterwards he began his career as a Neonatologist in the same city and over the 6 years he spent there, his career included both clinical and administrative duties including 4 years as the Fellowship Program Director and two years as the Medical Director for a level II unit. In late 2010 he accepted a position in Winnipeg to become the Section Head of Neonatology and continues to hold this post. In 2016 he took on the additional role of Medical Director of the Child Health Transport Team. In 2015 he became a member of the Canadian Pediatric Society’s Fetus and Newborn Committee and in 2019 took over as Chair of the same. His interests predominantly lie in the use of non-invasive technology to minimize painful procedures during an infants stay in the NICU. He is active on social media and has a passion for fundraising and is an active board member of the Children’s Hospital Foundation of Manitoba.

Canada Michael Narvey, MD, FAAP, FRCPC

Jaundice is one of the most common problems facing health care practioners in NICU. As we approach the 50th year of phototherapy this talk will explore some of the outstanding questions concerning diagnosis and treatment. Particular attention to the use of transcutaneous measurement and controversies pertaining to thresholds for treatment below 35 weeks gestational age will be discussed. Lastly we will explore how our current approach to jaundice may influence the risk of developing severe hyperbilirubinemia and chronic bilirubin encephalopathy (kernicterus) in a Canadian population.

View Full Presentation Information
Presentations: 10  |  Hours / CE Credits: 10.5  |  Viewing Time: 8 Weeks
This presentation is currently available through a bundled series of lectures.